Comparacion de biomarcadores sericos en pacientes con osteartritis y artritis rematoidea
DOI:
https://doi.org/10.15649/2346075X.473Palabras clave:
Osteoarthritis; Rheumatoid arthritis; Vitamin D; Parathyroid hormone; Type II collagenResumen
Introduction: This study aims to assess the status of serum vitamin D, parathyroid hormone, type II collagen, calcium, phosphate, albumin, and alkaline phosphatase in osteoarthritis and rheumatoid arthritis patients and to study their association with rheumatoid arthritis disease activity. Materials and Methods: This prospective cross-sectional study was conducted at the clinical analysis department, College of Pharmacy, Hawler Medical University in 2017. They study samples were collected at Rizgary Teaching Hospital
during the period September 2015 to January 2016. A total of (N=156) participants were included: (N=53) patients with rheumatoid arthritis (RA), (N=53) with osteoarthritis (OA), and (N=50) healthy controls. Enzyme Linked Immuno Sorbent Assay kits determined serum vitamin D, parathyroid hormone, and type II collagen; and serum albumin, calcium, phosphate and alkaline phosphatase, were determined by standard colorimetric methods. Results: and Discussion: Statistically significant higher levels of parathyroid hormone and type II collagen, with lower levels of Vitamin D, were found in the osteoarthritis group than the rheumatoid arthritis group and the healthy controls (P=0.007, P<0.001, P= 0.005) respectively. Multiple linear regression showed a statistically significant difference in serum type II collagen as a dependent variable, in
patients suffering from RA or OA compared to the healthy control group; after adjusting for the effect of other independent study variables, there was a mean increase of (45.90 nmol/L, P<0.001) in RA patients, and OA patients showed greater levels of type II collagen (73.950 nmol/L) than the health control group (P<0.001).
Conclusions: Elevated type II collagen levels, in conjunction with a low vitamin D status, may be strong discriminator between osteoarthritis and rheumatoid arthritis patients.
Referencias
McInnes IB and Schett G. The Pathogenesis of Rheumatoid Arthritis. N. Engl. J. Med., 2011; 365(23): 2205-19. https://doi.org/10.1056/NEJMra1004965
Doherty M, Ralston SH. Musculoskeletal disease. In: Colledge NR, Walker BR, Ralston SH, editors. Davidson's principles and practice of medicine. 21st ed. London, Churchill Livingstone; 2011. P. 1053-130. https://doi.org/10.1016/B978-0-7020-3085-7.00025-0
Shah A, Clair EWSt. Immune-mediated, inflammatory, and rheumatologic disorder. In: Kasper F, Longo H, Loscalzo J, editors. Harrison's principles of internal medicine. 19th ed. New York, McGraw-Hill; 2015. P. 2103-250.
Yazmalar L, Ediz L, Alpayci M, Hiz O, Toprak M, Tekeoglu I. Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Afr Health Sci. 2013; 13(1): 47-55. https://doi.org/10.4314/ahs.v13i1.7
Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab. 2012; 3(6): 181-7. https://doi.org/10.1177/2042018812471070
Heidari B, Heidari P, Hajian-Tilaki K. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop. 2011; 35(11): 1627-31. https://doi.org/10.1007/s00264-010-1186-2
Sanghi D, Mishra A, Sharma AC, Singh A, Natu SM, Agarwal S, et al. Reply to the Letter to the editor: Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial. Clin Orthop Relat Res. 2013; 471(11): 3716-7. https://doi.org/10.1007/s11999-013-3267-1
Rossini M, Bagnato G, Frediani B, Iagnocco A, LA Montagna G, Minisola G, et al. Relationship of focal erosions, bone mineral density, and parathyroid hormone in rheumatoid arthritis. J Rheumatol. 2011; 38(6): 997-1002. https://doi.org/10.3899/jrheum.100829
Eswaramoorthy R, Chang CC, Wu SC, Wang GJ, Chang JK, Ho ML. Sustained release of PTH (1-34) from PLGA microspheres suppresses osteoarthritis progression in rats. Acta Biomater.2012; 8(6): 2254-62. https://doi.org/10.1016/j.actbio.2012.03.015
Yan JY, Tian FM, Wang WY, Cheng Y, Song HP, Zhang YZ, et al. Parathyroid hormone (1-34) prevents cartilage degradation and preserves subchondral bone micro-architecture inguinea pigs with spontaneous osteoarthritis. Osteoarthritis Cartilage. 2014; 22(11): 1869-77. https://doi.org/10.1016/j.joca.2014.07.013
Jean-Gilles D, Li L, Vaidyanathan VG, King R, Cho B, Worthen DR, Chichester CO. Inhibitory effects of polyphenol punicalagin on type-II collagen degradation in vitro and inflammation in vivo. Chem Biol Interact. 2013; 205(2): 90-9. https://doi.org/10.1016/j.cbi.2013.06.018
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9): 2569-81. https://doi.org/10.1002/art.27584
Sorlie DE (ed). Medical biostatistics and epidemiology: Examination and Board review. First ed, Norwalk, Connecticut, Appleton and Lange. 1995: 47-88.
Jones G, Ding C, Scott F, Glisson M, Cicuttini F. Early radiographic osteoarthritis is associated with substantial changes in cartilage volume and tibial bone surface area in both males and females. Osteoarthritis Cartilage. 2004; 12(2): 169-74. https://doi.org/10.1016/j.joca.2003.08.010
Lin J, Liu J, Davies ML, Chen W. Serum vitamin D level and rheumatoid arthritis disease activity: Review and Meta-Analysis. PloS One. 2016; 11(1): e0146351. https://doi.org/10.1371/journal.pone.0146351
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7): 1911-30. https://doi.org/10.1210/jc.2011-0385
Chaganti RK, Parimi N, Cawthon P, Dam TL, Nevitt MC, Lane NE. Association of 25-hydroxyvitamin D with prevalent osteoarthritis of the hip in elderly men: The osteoporotic fractures in men study. Arthritis Rheum. 2010; 62(2): 511-4. https://doi.org/10.1002/art.27241
Goula T, Kouskoukis A, Drosos G, Tselepis AS, Ververidis A, Valkanis C, et al. Vitamin D status in patients with knee or hip osteoarthritis in a Mediterranean country. J Orthop Traumatol. 2015; 16(1): 35-9. https://doi.org/10.1007/s10195-014-0322-y
Von Hurst PR, Stonehouse W, Kruger MC, Coad J. Vitamin D supplementation suppresses age-induced bone turnover in older women who are vitamin D deficient. J Steroid Biochem Mol Biol. 2010; 121(1-2): 293-6. https://doi.org/10.1016/j.jsbmb.2010.03.054
Break K, Huang WY, Fraser DR, Ke L, Tseng M, Stolzenberg-Solomon R, et al. Low vitamin D status is associated with low physical activity, obesity, and low vitamin D intake in a large US sample of healthy middle age men and women. J Steroid Biochem Mol Biol. 2010; 121(1-2): 462-6. https://doi.org/10.1016/j.jsbmb.2010.03.091
Atwa MA, Balata MG, Hussein AM, Abdelrahman NI, Elminshawy HH. Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med J. 2013; 34(8): 806-13.
Grazio S, Naglić ĐB, Anić B, Grubišić F, Bobek D, Bakula M, et al. Vitamin D serum level, disease activity and functional ability in different rheumatic patients. Am J Med Sci. 2015; 349(1): 46-9. https://doi.org/10.1097/MAJ.0000000000000340
Lee YH, Bae SC. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol. 2016; 34(5): 827-33.
Liao H, Pan L, Ci W, Gao N, Wan J, Yang C, et al. Clinical significance of serum 25-hydroxyvitamin D in female patients with rheumatoid arthritis (abstract). Zhonghua Yi Xue Za Zhi. 2016; 96(3): 181-4.
Cozzolino M, Lu Y, Finch J, Slatopolsky E, Dusso AS. p21WAF1 and TGF-α mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 2001; 60(6): 2109-17. https://doi.org/10.1046/j.1523-1755.2001.00042.x
Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1, 25-dihydroxyvitamin D. J Biol Chem. 2002; 277(33): 30337-50. https://doi.org/10.1074/jbc.M201804200
Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997; 7(5): 439-43. https://doi.org/10.1007/s001980050030
Li H, Zeng C, Wei J, Yang T, Gao SG, Li YS, et al. Serum calcium concentration is inversely associated with radiographic knee osteoarthritis: a cross-sectional study. Medicine (Baltimore). 2016; 95(6): e2838. https://doi.org/10.1097/MD.0000000000002838
Mwale F, Yao G, Ouellet JA, Petit A, Antoniou J. Effect of parathyroid hormone on type X and type II collagen expression in mesenchymal stem cells from osteoarthritic patients. Tissue Eng Part A. 2010; 16(11): 3449-55. https://doi.org/10.1089/ten.tea.2010.0091
Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone. 2001; 29(3): 209-15. https://doi.org/10.1016/S8756-3282(01)00504-X
Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of cross linked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum. 2003; 48(11): 3130-9.https://doi.org/10.1002/art.11326
Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997; 99(7): 1534-45. https://doi.org/10.1172/JCI119316
Descargas
Publicado
Cómo citar
Número
Sección
Altmetrics
Descargas
Licencia
Todos los artículos publicados en esta revista científica están protegidos por los derechos de autor. Los autores retienen los derechos de autor y conceden a la revista el derecho de primera publicación con el trabajo simultáneamente licenciado bajo una Licencia Creative Commons Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) que permite compartir el trabajo con reconocimiento de autoría y sin fines comerciales.
Los lectores pueden copiar y distribuir el material de este número de la revista para fines no comerciales en cualquier medio, siempre que se cite el trabajo original y se den crédito a los autores y a la revista.
Cualquier uso comercial del material de esta revista está estrictamente prohibido sin el permiso por escrito del titular de los derechos de autor.
Para obtener más información sobre los derechos de autor de la revista y las políticas de acceso abierto, por favor visite nuestro sitio web.